Michigan ALS clinic faces data gap as state tracking system stalls
The University of Michigan ALS clinic treats 300 patients but cannot report cases under state law until a pilot system is fully operational.
By Mei Chen ·

The University of Michigan ALS clinic has not submitted a single case to state health officials since Michigan made reporting mandatory in 2025. The clinic, which treats close to 300 people at any given time, is waiting for guidance from the Michigan health department before it can begin the data collection process.
Amyotrophic lateral sclerosis, commonly known as ALS, is not currently a federally mandated reportable disease. Only eight states, including Michigan, have chosen to require local reporting. This gap in data prevents researchers from mapping the spread of the disease across the country. The number of Americans with ALS is projected to reach 35,000 in 2026, up from nearly 33,000 in 2022.
Dr. Stephen Goutman, director of the University of Michigan ALS clinic, said the lack of location data hinders efforts to identify environmental triggers. He noted that patients exposed to metals appear to have a higher risk of developing the condition. Ben Murdock, an associate professor of neurology at the same institution, explained that tracking patient addresses allows scientists to correlate disease clusters with specific geographic areas. He said this information is essential for understanding why the rates of the disease are rising.
The disease is fatal and destroys the nerve cells that control voluntary muscle movement. The average life expectancy after diagnosis is three years. There have been few new treatments in over 30 years, with the drug Riluzole remaining the primary option. Murdock stated that Riluzole extends life by approximately two to three months, though researchers aim for therapies that add at least six months.
Jennifer Robb from Missouri diagnosed with ALS two years ago. She has since lost the ability to walk and eat most solid food. Her husband, Eric Robb, left his teaching job to become her full-time caregiver. He described the daily routine as increasingly difficult, noting that bedtime now takes two hours. Missouri is not one of the states tracking the disease, so health officials in her home county of fewer than 40,000 people do not know she is a patient.
Congress approved $315 million in funding for ALS research in early 2026. This amount is the highest level of funding ever allocated to the disease. For comparison, cancer receives $8.1 billion and Alzheimer's disease receives $3.9 billion. The ALS Association argues that higher funding will lead to new answers, but researchers contend that accurate case counts are the first step toward finding a cure.






